or Try an Advanced Search...

    Technical Analysis for ABIO - ARCA biopharma, Inc.

    Grade Last Price % Change Price Change
    B 3.83 2.88% 0.11
    ABIO closed up 12.05 percent on Wednesday, May 15, 2024, on 11 percent of normal volume.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Up Up Up
    Historical ABIO trend table...
    Date Alert Name Type % Chg
    Crossed Above 20 DMA Bullish 2.88%
    New 52 Week Closing High Bullish 2.88%
    Pocket Pivot Bullish Swing Setup 2.88%
    Above Upper BB Strength 2.88%
    Gapped Up Strength 2.88%
    Upper Bollinger Band Touch Strength 2.88%
    Fell Below 20 DMA Bearish 15.27%
    Inside Day Range Contraction 15.27%
    20 DMA Support Bullish 12.56%
    Wide Range Bar Range Expansion 12.56%
    Older End-of-Day Signals for ABIO ...

       Recent Intraday Alerts

    Alert Time
    Rose Above Previous Day's High 40 minutes ago
    New 52 Week High 40 minutes ago
    Up 3% 40 minutes ago
    Up 2% 40 minutes ago
    Up 1% 40 minutes ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    ABIO Chart by TradingView
    Basic chart:

    Profile

    ARCA biopharma, Inc., a biopharmaceutical company, focuses on developing genetically-targeted therapies for cardiovascular diseases. Its lead product candidate is Gencaro, a pharmacologically unique beta-blocker and mild vasodilator for the treatment of atrial fibrillation in patients with heart failure and left ventricular dysfunction. ARCA biopharma, Inc. is headquartered in Broomfield, Colorado.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biopharmaceutical Cardiovascular Disease Heart Failure Vascular Disease Dysfunction Heart Disease Cardiac Arrhythmia Atrial Fibrillation Ventricular Dysfunction

    Is ABIO a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 25 ARCA biopharma GAAP EPS of -$0.14
    Apr 25 ARCA biopharma Announces First Quarter 2024 Financial Results and Provides Corporate Update
    Apr 3 Small-Cap ARCA Biopharma Stock Soars On Merger Pact: The Details
    Apr 3 ARCA biopharma to merge with Oruka Therapeutics in all-stock transaction
    Apr 3 ARCA biopharma and Oruka Therapeutics Announce Merger Agreement
    Dec 20 We're Not Very Worried About ARCA biopharma's (NASDAQ:ABIO) Cash Burn Rate
    See more ABIO news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 3.88
    52 Week Low 1.56
    Average Volume 1,805,586
    200-Day Moving Average 2.07
    50-Day Moving Average 2.71
    20-Day Moving Average 3.41
    10-Day Moving Average 3.37
    Average True Range 0.25
    RSI (14) 68.45
    ADX 48.61
    +DI 32.64
    -DI 14.23
    Chandelier Exit (Long, 3 ATRs) 3.04
    Chandelier Exit (Short, 3 ATRs) 3.83
    Upper Bollinger Bands 3.70
    Lower Bollinger Band 3.13
    Percent B (%b) 1.04
    BandWidth 16.70
    MACD Line 0.18
    MACD Signal Line 0.21
    MACD Histogram -0.0307
    Fundamentals Value
    Market Cap 53.94 Million
    Num Shares 14.5 Million
    EPS -0.37
    Price-to-Earnings (P/E) Ratio -10.05
    Price-to-Sales 0.00
    Price-to-Book 0.65
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 4.27
    Resistance 3 (R3) 4.23 4.01 4.18
    Resistance 2 (R2) 4.01 3.87 4.03 4.15
    Resistance 1 (R1) 3.86 3.78 3.94 3.90 4.12
    Pivot Point 3.64 3.64 3.68 3.66 3.64
    Support 1 (S1) 3.50 3.50 3.57 3.54 3.32
    Support 2 (S2) 3.28 3.42 3.30 3.29
    Support 3 (S3) 3.13 3.28 3.26
    Support 4 (S4) 3.17